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Abstract: Deep Brain Stimulation, especially STN-DBS, is one of the most prevalent treatments for the Parkinson’s 
Disease. Previous researches already showed its positive effects on the general conditions of the patients but lack evalu-
ation of its influence on the cognitive ability of the patients. A comparison in the effect of DBS and surgical lesioning 
procedures can determine DBS’s influence on the quality of life and confirm whether it is the most optimal treatment. 
This proposal reviewed previous researches about the influence of STN-DBS and proposed a study on its influence of 
patients’ cognitive ability. 
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1. Introduction 
As Marras et al’s estimation predicted in 2018, the 
number of patients with the Parkinson’s Disease (PD) 
would be approximately 0.93 million in 2020 and would 
grow to 1.23 million in 2030. This is more than the com-
bined number of people diagnosed with multiple sclero-
sis, muscular dystrophy and amyotrophic lateral sclerosis. 
The prevalence of the Parkinson’s Disease not only adds 
great obstacles to the patients’ life, but also poses intense 
financial burden on the families and the taxpayers. Lew-
in Group Inc’s research in 2019 concluded that the direct 
medical cost of Parkinson’s Disease in America is $25.4 
million, while the non-medical cost is $26.5 million dol-
lar. Deep Brain Stimulation (DBS) surgery was first ap-
proved in 1997 to treat Parkinson’s Disease (PD) tremor, 
then in 2002 for the treatment of advanced Parkinson’s. 
Although numerous studies showed the alleviation of 
dyskinesias, studying Deep Brain Stimulation’s influence 
on the patients’ cognitive abilities is helpful for deter-
mining whether DBS can sustain the quality of life of the 
patients. 
2. Literature review & rationale 
The author has been interested in exploring the 
causes and treatments of Parkinson’s Disease ever since I 
watched a video one year ago on an animal demonstra-
tion of the disease. The experimental mouse shaking its 
head relentlessly but painfully struck me and got my 
attention into this not-often-mentioned but truly striking 
disease
[1]
. Currently, deep brain stimulation is one of the 
most common treatments for patients with Parkinson 
Disease. The most prevalent type of DBS is subthalamic 
nucleus (STN) DBS
[4]
. Evaluating the effectiveness and 
the potential risk of the treatment is crucial. However, 
most of the studies focused on the effects of different 
treatments on their decision-making or physical abilities 
while ignoring their cognitive domain
[2]
. 
Globus pallidal deep brain stimulation for Tourette 
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syndrome: Effects on cognitive function by Cappon, et al. 
examined the influence of bilateral deep brain stimula-
tion of the anteromedial globus pallidus internus 
(GPiam-DBS) on the cognitive ability of patients with 
Tourette syndrome. They found a positive influence on 
the severity of the syndrome, but an insignificant influ-
ence on the cognitive ability of the patients
[2]
. Decline in 
drawing ability and cerebral perfusion in Parkinson’s 
Disease patients after subthalamic nucleus deep brain 
stimulation surgery by Furukawa, et al., examined 21 
patients with PD and utilized perfusion SPECT to find a 
decrease of cerebral blood flow in the prefrontal and 
cingulate cortex after surgery. This is also reflected by a 
decline in the drawing abilities of the participants. This 
study shows that there may be a side effect of the DBS 




Furthermore, multiple studies focused on a compar-
ison between the surgical lesioning procedures’ and the 
DBS’s damage to the brain tissues concluded that Deep 
Brain Stimulation has a lower damage
[1,5-7]
. These studies 
show the importance of comparison between different 
treatments: even if DBS may negatively influence the 
cognitive ability of the patients, it may still be a better 
choice than surgical lesioning procedures
[4]
. 
These studies inspired me to evaluate whether the 
same relationship exists in that of Parkinson patients. 
Therefore, this study will examine the effect of Deep 






All the participants of the experiment are PD pa-
tients. To ensure that the severity of PD of each partici-
pant is roughly the same, Multiple Sclerosis Functional 
Composite (MSFC) would be used. The patients will be 
assigned in to two groups based on the treatment they 




All the participants should take the cognitive 
test before and 3-6 months after using deep brain stimu-
lation. The patients were evaluated on tests of memory 
(Short Recognition Memory for Faces), executive func-
tion (verbal fluency, Hayling Sentence Completion Test), 
and attention (Numbers and Letters Test)
[7]
. Sin-
gle-Photon Emission Computed Tomography (SPECT) 
will be used to examine the blood flow in different areas 
of the cerebrum to reflect the brain activity, providing 





Deep Brain Stimulation, especially STN-DBS, is 
one of the most prevalent treatments for the Parkinson’s 
Disease. Previous researches already showed its positive 
effects on the general conditions of the patients but 
didn’t evaluate its influence on the cognitive ability of 
the patients. A comparison in the effect of DBS and sur-
gical lesioning procedures can determine DBS’s influ-
ence on the quality of life and confirm whether it is the 
most optimal treatment. Evaluating its influence on cog-
nitive abilities can enables the patients to make better 
informed decisions on their treatment choices. 
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